Rationale and design for programming implantable cardioverterdefibrillators in patients with primary prevention indication to prolong time to first shock (PROVIDE) study

Europace

Volumn 13, Issue 11, 2011, Pages 1648-1652

  Saeed, Mohammad ^a   Razavi, Mehdi ^a   Neason, Curtis G ^b   Petrutiu, Simona ^b  

^a ST LUKE S EPISCOPAL HOSPITAL   (United States)

^b ST JUDE MEDICAL   (United States)

Author keywords

Anti tachycardia pacing; Implantable cardioverterdefibrillator; Sudden cardiac death; Ventricular fibrillation; Ventricular tachycardia

Indexed keywords

ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; DEFIBRILLATOR; ELECTRIC SHOCK; HEART VENTRICLE TACHYCARDIA; HUMAN; METHODOLOGY; MONITORING; MULTICENTER STUDY (TOPIC); PATIENT SAFETY; PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SUDDEN DEATH; SUPRAVENTRICULAR TACHYCARDIA; SYNCOPE;

CARDIAC PACING, ARTIFICIAL; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; HUMANS; INCIDENCE; PRIMARY PREVENTION; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SYNCOPE; TACHYCARDIA, SUPRAVENTRICULAR; TIME FACTORS;

EID: 80054941931     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eur195     Document Type: Article

References (14)

1. Moss A, Hall W, Cannom D, Daubert J, Higgins S, Klein H et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335:1933-40. (Pubitemid 26428217)
2. Buxton A, Lee K, Fisher J, Josephson M, Prystowsky E, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 1999;341:1882-90.
3. Bardy G, Lee K, Mark D, Poole J, Packer D, Boineau R et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37. (Pubitemid 40110811)
4. Schron E, Exner D, Yao Q, Jenkins L, Steinberg J, Cook J et al. Quality of life in the antiarrhythmics versus implantable defibrillators trial. impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation 2002;105: 589-94. (Pubitemid 34123433)
5. Irvine J, Dorian P, Baker B, O'Brien B, Roberts R, Gent M et al. Quality of life in the Canadian Implantable Defibrillator Study (CIDS). Am Heart J 2002;144:282-9. (Pubitemid 34879652)
6. Carrol D, Hamilton G. Quality of life in implanted cardioverter defibrillator recipients: The impact of a device shock. Heart Lung 2005;34:169-78. (Pubitemid 40704565)
7. Wathen M, DeGroot P, Sweeney M, Stark A, Otterness M, AdkissonWet al. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation 2004;110:2591-6. (Pubitemid 39453007)
8. Wilkoff B, Ousdigian K, Sterns L, Wang Z, Wilson R, Morgan. A comparison of empiric to physician-tailored programming of implantable cardioverter- defibrillators: Results from the prospective randomized multicenter EMPIRIC trial. J Am Coll Cardiol 2006;48:330-9.
9. Saeed M, Neason C, Razavi M, Chandiramani S, Alonso J, Natarajan S et al. Programming antitachycardia pacing for primary prevention in patients with implantable cardioverter defibrillators: Results from the PROVE trial. J Cardiovasc Electrophysiol 2010;21:1349-54.
10. Wilkoff B, Williamson B, Stern R, Moore S, Lu F, Lee S et al. Strategic programming of detection and therapy parameters in implantable cardioverterdefibrillators reduces shocks in primary prevention patients: Results from the PREPARE (Primary Prevention Parameters Evaluation) study. J Am Coll Cardiol 2008;52:541-50.
11. Boriani G, Occhetta E, Pistis G, Menozzi C, Jorfida M, Sermasi S et al. Combined use of morphology discrimination, sudden onset, and stability as discriminating algorithms in single chamber cardioverter defibrillators. Pacing Clin Electrophysiol 2002;25:1357-66.
12. Theuns D, Rivero-Ayerza M, Goedhart D, van der Perk R, Jordaens L. Evaluation of morphology discrimination for ventricular tachycardia diagnosis in implantable cardioverter-defibrillators. Heart Rhythm 2006;3:1332-8. (Pubitemid 44615661)
13. Epstein A, Dimarco J, Ellenbogen K, Estes N, Freedman R, Gettes L et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: Executive summary. Heart Rhythm 2008;5:934-55.
14. Collett D. Modelling. Survival Data in Medical Research. 2nd edition. Chapman and Hall, CRC; CRC Press LLC.